Other Languages1. A pharmacist’s application of guidelines or protocols previously established in a collaborative drug therapy agreement is statutorily authorized, even if it amounts to diagnosis of a patient’s condition.
2. Under limited circumstances, a physician or physician assistant may enter into a collaborative drug treatment agreement that permits the diagnosis by a pharmacist of a patient’s condition.
3. There is no statutory or administrative requirement that a collaborative drug treatment agreement call for direct contact between a physician or physician assistant and a patient.
4. A pharmacist who diagnoses patients pursuant to a collaborative drug treatment agreement with a physician or a physician assistant does not commit an act of unlicensed practice of medicine under RCW 18.130.190 if the pharmacist acts within the scope of guidelines previously established under a collaborative drug treatment agreement